Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma.
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
S K
SK
Kumar
Millennium Pharmaceuticals Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
E
E
Ma
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
A E
AE
Engebretson
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
F K
FK
Buadi
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
M Q
MQ
Lacy
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
A
A
Dispenzieri
Analysis Group, Inc, Boston, MA, USA.
M S
MS
Duh
Analysis Group, Inc, Boston, MA, USA.
M-H
MH
Lafeuille
Groupe d'analyse, Ltée, Montreal, QC, Canada.
P
P
Lefebvre
Analysis Group, Inc, Boston, MA, USA.
W Y
WY
Cheng
Groupe d'analyse, Ltée, Montreal, QC, Canada.
K
K
Dea
McKesson Specialty Health, The Woodlands, TX, USA.
D
D
Rembert
McKesson Specialty Health, The Woodlands, TX, USA.
D
D
Patt
Millennium Pharmaceuticals Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
L
L
Niculescu
Millennium Pharmaceuticals Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
M
M
Quick
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
S V
SV
Rajkumar
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics* / Q000627:therapeutic use*; D000069286:Bortezomib / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D005500:Follow-Up Studies; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006295:Health Resources / Q000706:statistics & numerical data*; D006801:Humans; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics* / Q000401:mortality; D009367:Neoplasm Staging; D011379:Prognosis; D015996:Survival Rate; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives
D013792:Thalidomide; D000069286:Bortezomib; D003907:Dexamethasone; D003520:Cyclophosphamide; D000077269:Lenalidomide